Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma - 10/10/20
Doi : 10.1016/j.jaad.2020.04.186
Michael A. Marchetti, MD a, ⁎ 
, Stephen W. Dusza, DrPH a, Edmund K. Bartlett, MD b
, Stephen W. Dusza, DrPH a, Edmund K. Bartlett, MD b a Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
b Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
∗Reprint requests: Michael A. Marchetti, MD, Dermatology Service, Memorial Sloan Kettering Cancer Center, 545 E 73rd St, New York, NY, 10021Dermatology ServiceMemorial Sloan Kettering Cancer Center545 E 73rd StNew YorkNY10021
Il testo completo di questo articolo è disponibile in PDF.
| Funding source: Supported in part by a grant from the National Cancer Institute/National Institutes of Health (P30-CA008748). |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
© 2020
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 83 - N° 5
P. e357-e358 - novembre 2020 Ritorno al numero
Articolo precedente
- Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss
- Diego Fernandez-Nieto, David Saceda-Corralo, Juan Jimenez-Cauhe, Oscar Muñoz Moreno-Arrones, Rita Rodrigues-Barata, Angela Hermosa-Gelbard, Sergio Vano-Galvan
- Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma
- Bradley N. Greenhaw, Kyle R. Covington, Sarah J. Kurley, Yildiray Yeniay, Nhat Anh Cao, Kristen M. Plasseraud, Robert W. Cook, Eddy C. Hsueh, Brian R. Gastman, Maria L. Wei
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?